naphthalimides has been researched along with Adenocarcinoma in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (61.54) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carling, D; Graham, R; Kent, TR; Muckett, P; Nikitin, AY; Penfold, L; Pollard, A; Woods, A; Zhang, S | 1 |
| Cheng, Z; Li, Q; Liang, X; Liu, J; Qian, X; Wang, Z; Xu, Y; Yin, P; Zhu, H | 1 |
| Cheng, WP; Cordeiro-da-Silva, A; Hoskins, C; Kong Thoo Lin, P; Lima, SC; Lombardo, D; Loureirio, I; Mas, E; Ouaissi, A; Ouaissi, M | 1 |
| Gust, R; Krüger, M; Richter, J; Scutaru, AM; Wenzel, M | 1 |
| Bestwick, CS; Duthie, SJ; Kong Thoo Lin, P; Milne, L; Ralton, LD | 1 |
| Bauman, A; Benson, AB; Blough, RR; Carroll, RB; French, SL; Kilton, LJ; Mullane, MR; Schilsky, RL; Wade, JL | 1 |
| Ahmann, F; Blumenstein, B; Craig, JB; Crawford, ED; Eisenberger, M; Marshall, ME; Thompson, IM | 1 |
| Alberts, DS; Craig, JB; Liu, PY; Malviya, VK; O'Sullivan, J; O'Toole, R; Rosenoff, S; Surwit, E; Ward, JH; Yu, A | 1 |
| Brown, TD; Craig, JB; Einstein, AB; Fleming, T; Goodman, PJ; Macdonald, JS | 1 |
| Adams, GL; Dutcher, JP; Leaf, AN; Neuberg, D; Ritch, PS; Schwartz, EL; Wadler, S | 1 |
| Abbruzzese, JL; Ajani, JA; Bradof, JE; Daugherty, K; Levin, B; Linke, K; Pazdur, R; Winn, R | 1 |
| Berger, MZ; Dimaggio, JJ; Gralla, RJ; Heelan, RT; Kris, MG; Marks, LD; Potanovich, LM | 1 |
| Comis, RL; Hudes, GR; O'Dwyer, PJ; Ozols, RF; Paul, AR; Walczak, J | 1 |
7 trial(s) available for naphthalimides and Adenocarcinoma
| Article | Year |
|---|---|
Phase II study of amonafide in gastric adenocarcinoma. An Illinois Cancer Center trial.
Topics: Adenine; Adenocarcinoma; Antineoplastic Agents; Female; Hematologic Diseases; Humans; Imides; Isoquinolines; Male; Naphthalimides; Organophosphonates; Stomach Neoplasms | 1994 |
Phase II trial of amonafide for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group study.
Topics: Adenine; Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Drug Administration Schedule; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Neoplasms, Hormone-Dependent; Organophosphonates; Prostatic Neoplasms; Remission Induction | 1994 |
Phase II trial of amonafide in patients with advanced metastatic or recurrent endometrial adenocarcinoma. A Southwest Oncology Group study.
Topics: Adenine; Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Endometrial Neoplasms; Female; Humans; Imides; Intercalating Agents; Isoquinolines; Middle Aged; Naphthalimides; Neoplasm Recurrence, Local; Organophosphonates; Survival Analysis; Treatment Outcome | 1994 |
Phase II trial of amonafide in advanced colorectal cancer: a SouthWest Oncology Group study.
Topics: Adenine; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Colorectal Neoplasms; Female; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Organophosphonates | 1993 |
An ECOG phase II study of amonafide in unresectable or recurrent carcinoma of the head and neck (PB390). Eastern Cooperative Oncology Group.
Topics: Adenine; Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Organophosphonates | 1997 |
Phase II study of amonafide in advanced pancreatic adenocarcinoma.
Topics: Adenine; Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Organophosphonates; Pancreatic Neoplasms | 1991 |
Phase II study of amonafide (nafidamide, NSC 308847) in advanced colorectal cancer.
Topics: Adenine; Adenocarcinoma; Antineoplastic Agents; Colorectal Neoplasms; Drug Evaluation; Humans; Imides; Isoquinolines; Middle Aged; Naphthalimides; Organophosphonates | 1991 |
6 other study(ies) available for naphthalimides and Adenocarcinoma
| Article | Year |
|---|---|
CAMKK2 Promotes Prostate Cancer Independently of AMPK via Increased Lipogenesis.
Topics: Adenocarcinoma; AMP-Activated Protein Kinases; Animals; Benzimidazoles; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; CRISPR-Cas Systems; Female; Gene Deletion; Humans; Lipogenesis; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Naphthalimides; Neoplasm Invasiveness; Phosphorylation; Prostatic Neoplasms; Receptors, Androgen; Signal Transduction | 2018 |
Induction of apoptosis and suppression of ERCC1 expression by the potent amonafide analogue 8-c in human colorectal carcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Shape; Colorectal Neoplasms; Comet Assay; DNA Damage; DNA Repair; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Endonucleases; Gene Expression Regulation, Neoplastic; Humans; Naphthalimides; Neoplasm Proteins; RNA Interference; RNA, Small Interfering; Single-Cell Analysis | 2013 |
In vitro and in vivo anticancer activity of a novel nano-sized formulation based on self-assembling polymers against pancreatic cancer.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; In Vitro Techniques; Inhibitory Concentration 50; Mice; Nanotechnology; Naphthalimides; Pancreatic Neoplasms; Polymers; Xenograft Model Antitumor Assays | 2010 |
Investigations on the use of fluorescence dyes for labeling dendrimers: cytotoxicity, accumulation kinetics, and intracellular distribution.
Topics: Adenocarcinoma; Benzene Derivatives; Breast Neoplasms; Cell Line, Tumor; Cell Nucleus; Cell Survival; Dansyl Compounds; Dendrimers; Drug Delivery Systems; Endosomes; Female; Fluorescein-5-isothiocyanate; Fluorescence; Fluorescent Dyes; Humans; Kinetics; Microscopy, Confocal; Naphthalimides | 2010 |
The influence of bisnaphthalimidopropyl polyamines on DNA instability and repair in Caco-2 colon epithelial cells.
Topics: Adenocarcinoma; Apoptosis; Caco-2 Cells; Cell Survival; Colonic Neoplasms; Comet Assay; DNA; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Humans; Hydrogen Peroxide; Inhibitory Concentration 50; Intercalating Agents; Naphthalimides; Oxidation-Reduction; Quinolones; Spermine | 2011 |
Phase II trial of amonafide in patients with stage III and IV non-small-cell lung cancer.
Topics: Adenine; Adenocarcinoma; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Drug Tolerance; Female; Humans; Imides; Intercalating Agents; Isoquinolines; Lung Neoplasms; Male; Middle Aged; Naphthalimides; Neoplasm Staging; Organophosphonates; Remission Induction | 1991 |